213 related articles for article (PubMed ID: 33010467)
21. Does type of cancer affect ovarian response in oncofertility patients?
Hussein RS; Zhao Y; Khan Z
J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101944. PubMed ID: 33069914
[TBL] [Abstract][Full Text] [Related]
22. The Significance of Planned Fertility Preservation for Women With Endometrioma Before an Expected Ovarian Cystectomy.
Hong YH; Lee HK; Kim SK; Lee JR; Suh CS
Front Endocrinol (Lausanne); 2021; 12():794117. PubMed ID: 34975763
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
Ciccarone M; Hohaus S; Pulsoni A; Cavaceppi P; Franzò S; Fabbri R; Cudillo L; Battistini R; Di Rocco A; Annibali O; Cox MC; Provenzano I; Abruzzese E; Renzi D; Tesei C; Anticoli Borza P; Cuccaro A; Andriani A; D'Elia GM; Facchiano A; Marchetti P; Cantonetti M
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13174. PubMed ID: 31571303
[TBL] [Abstract][Full Text] [Related]
24. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
25. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
26. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
27. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
[TBL] [Abstract][Full Text] [Related]
28. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
[TBL] [Abstract][Full Text] [Related]
29. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
30. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
31. Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers.
Goldrat O; Van Den Steen G; Gonzalez-Merino E; Dechène J; Gervy C; Delbaere A; Devreker F; De Maertelaer V; Demeestere I
Reprod Biol Endocrinol; 2019 Jan; 17(1):3. PubMed ID: 30606204
[TBL] [Abstract][Full Text] [Related]
32. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
33. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
[TBL] [Abstract][Full Text] [Related]
34. Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation.
Vergier J; Bottin P; Saias J; Reynaud R; Guillemain C; Courbiere B
Clin Endocrinol (Oxf); 2019 Nov; 91(5):646-651. PubMed ID: 31420888
[TBL] [Abstract][Full Text] [Related]
35. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
36. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
Cobo A; Giles J; Paolelli S; Pellicer A; Remohí J; García-Velasco JA
Fertil Steril; 2020 Apr; 113(4):836-844. PubMed ID: 32145929
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
[TBL] [Abstract][Full Text] [Related]
38. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
39. Oocyte cryopreservation for women with GATA2 deficiency.
Zolton JR; Parikh TP; Hickstein DD; Holland SM; Hill MJ; DeCherney AH; Wolff EF
J Assist Reprod Genet; 2018 Jul; 35(7):1201-1207. PubMed ID: 29532200
[TBL] [Abstract][Full Text] [Related]
40. PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.
Yovich JL; Alsbjerg B; Conceicao JL; Hinchliffe PM; Keane KN
Drug Des Devel Ther; 2016; 10():2561-73. PubMed ID: 27563236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
